Expert Opinion on Investigational Drugs (ISSN 1354-3784 [print], 1744-7658 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on drugs in preclinical and early stage clinical development, providing expert opinion on the scope for future development.
The Editors welcome:
Reviews covering preclinical through to Phase II data on drugs or drug classes for specific indications, and their potential impact on future treatment strategies
Drug Evaluations reviewing the clinical and pharmacological data on a particular drug
Original Research papers reporting the results of clinical investigations on agents that are in Phase I and II clinical trials
The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D. 

EDITOR-IN-CHIEF 
Giuseppe Tonini - University Campus Bio-Medico, Italy

EDITORIAL ADVISORY BOARD
Naim Alkhouri - Texas Liver Institute, San Antonio, Texas, USA 
Karl-Eric Andersson - Wake Forest University, NC, USA 
Wilbert Aronow - New York Medical College, NY , USA 
Guglielmo Borgia - University of Naples Federico II, Italy 
Martin Braddock - AstraZeneca, Loughborough, England, UK 
Maria Luisa Brandi - University of Florence, Italy 
Linda Cardozo - King's College London, England, UK 
Thomas Ciulla - Indiana University School of Medicine, Indianapolis, IN, USA 
Jerry Colca - Kalamazoo Metabolic Research, MI, USA 
Mellar Davis - Taussig Cancer Institute, OH, USA 
William Denny - University of Auckland, New Zealand 
Nafsika Georgopapadakou - MethylGene, Montreal, Canada 
Lars Grundemar - Ferring Pharmaceuticals, Denmark 
Percy Ivy – National Cancer Institute, MD, USA 
Michael Koutsilieris - University of Athens, Greece 
Renu Kowluru - Kresge Eye Institute, MI, USA 
Dimitri Mikhalidis - University College London, England, UK 
Nouri Naemati - University of Southern California, CA, USA 
Athanasios Papatsoris - University of Athens, Greece 
Athanasios Papavassiliou - University of Athens, Greece 
Godefridus J. Peters - Amsterdam UMC, The Netherlands 
Marwan N Sabbagh - Banner Sun Health Research Institute, USA 
Tomi Sawyer - Merck Research Laboratories, MA, USA 
Nicola Silvestris – Cancer Institute, 'Giovanni Paolo II’, Italy 
Noel J Snell - Royal Brompton Hospital, London, England, UK 
Guru Sonpavde - Dana Farber Cancer Institute, MA, USA 
Christoph Stein - Charité Campus Benjamin Franklin, Berlin, Germany 
Eleftherios Tsiridis - Imperial College, London, England, UK 
László Vecsei - University of Szeged, Hungary 
Stephan von Haehling - University of Göttingen, Germany 
Robert Williams - Cancer Research UK 
Martyn Wood - UCB Pharma, Belgium